| scholarly article | Q13442814 |
| P2093 | author name string | Humberto Marin | |
| Matthew Menza | |||
| Karina L Bienfait | |||
| Lesley A Allen | |||
| Jade Tiu | |||
| Jennifer Howarth | |||
| Roseanne Defronzo Dobkin | |||
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research | Q29547257 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials | Q30870451 | ||
| Postmenopausal hormone replacement therapy: scientific review | Q33184140 | ||
| Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review | Q33251613 | ||
| The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy | Q78550526 | ||
| Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey | Q80410584 | ||
| The role of serotonin in hot flushes | Q34076822 | ||
| A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. | Q34127315 | ||
| Escitalopram : a review of its use in the management of major depressive and anxiety disorders | Q34186994 | ||
| Constructing a standard climacteric scale | Q34473577 | ||
| Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis | Q34567208 | ||
| Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women | Q34649417 | ||
| Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995. | Q34746425 | ||
| Medical choices available for management of menopause | Q35134582 | ||
| Hot flashes--a review of the literature on alternative and complementary treatment approaches | Q35208390 | ||
| Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women | Q35855753 | ||
| The role of complementary and alternative medicine in management of menopausal symptoms. | Q35926433 | ||
| Noradrenergic and serotonergic modulation to treat vasomotor symptoms | Q36411851 | ||
| Clinical practice. Management of menopausal symptoms | Q36668701 | ||
| Psychological and sexual aspects of the menopause | Q37774905 | ||
| Management of menopause when estrogen cannot be used | Q37977343 | ||
| Soy isoflavones and melatonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. | Q39386058 | ||
| Treatment of hot flushes with mirtazapine: four case reports | Q39425147 | ||
| Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial | Q39651148 | ||
| Psychological and Sexual Symptoms Associated with the Menopause and the Effects of Hormone Replacement Therapy | Q40427487 | ||
| Hormone replacement therapy and endometrial cancer risk: a meta-analysis | Q40571296 | ||
| Perimenopausal women in estrogen vasomotor trials: contribution to placebo effect and efficacy outcome | Q40705476 | ||
| Well-being, symptoms and the menopausal transition | Q40948196 | ||
| Methodologic lessons learned from hot flash studies | Q43814453 | ||
| Phase III evaluation of fluoxetine for treatment of hot flashes | Q43918780 | ||
| Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care | Q43974546 | ||
| Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients | Q43986319 | ||
| Failure of estrogen plus progestin therapy for prevention | Q44063678 | ||
| Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial | Q44456433 | ||
| Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial | Q44471378 | ||
| Making a decision about ERT/HRT. Evidence to consider in initiating and continuing protective therapy | Q44880342 | ||
| Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study | Q45236864 | ||
| Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial | Q46726895 | ||
| Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial | Q46828421 | ||
| Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life | Q48493518 | ||
| A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors | Q48730571 | ||
| Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. | Q50672431 | ||
| A menopause-specific quality of life questionnaire: development and psychometric properties. | Q53621065 | ||
| Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis | Q57739558 | ||
| Treatment of menopausal hot flashes with transdermal administration of clonidine | Q69773754 | ||
| Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial | Q73365346 | ||
| Adherence to postmenopausal hormone therapy during the year after the initial prescription: A population-based study | Q73492085 | ||
| Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention | Q74329019 | ||
| Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors | Q74784094 | ||
| P433 | issue | 2 | |
| P921 | main subject | escitalopram | Q423757 |
| hot flash | Q1858291 | ||
| P304 | page(s) | 70-76 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | Annals of Clinical Psychiatry | Q15716688 |
| P1476 | title | Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study | |
| P478 | volume | 21 |
| Q35092002 | A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients |
| Q35086586 | Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial |
| Q35234675 | Escitalopram treatment of menopausal hot flashes |
| Q35919965 | Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms |
| Q35936499 | Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trial |
Search more.